 | • レポートコード：GIR-22F4596 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Orally Dissolving Tablets (ODT) Excipient Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の口腔内崩壊錠（ODT）賦形剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 口腔内崩壊錠（ODT）賦形剤市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・結合剤、流動化剤、希釈剤、崩壊剤、甘味料、その他 アプリケーション別セグメントは次のように区分されます。 ・抗精神病薬、抗てんかん薬、その他 世界の口腔内崩壊錠（ODT）賦形剤市場の主要な市場プレーヤーは以下のとおりです。 ・BASF、JRS Pharma、Roquette、ABF Ingredients、DFE Pharma、Evonik、Merck KGaA、Ashland、Meggle Pharma、Shin-Etsu、Fuji Chemical Industries、McePharma (Vivesa holding)、Cargill Incorporated、Daicel Corporation、Anhui Sunhere Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、口腔内崩壊錠（ODT）賦形剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な口腔内崩壊錠（ODT）賦形剤メーカーの企業概要、2019年～2022年までの口腔内崩壊錠（ODT）賦形剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な口腔内崩壊錠（ODT）賦形剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別口腔内崩壊錠（ODT）賦形剤の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの口腔内崩壊錠（ODT）賦形剤のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での口腔内崩壊錠（ODT）賦形剤市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および口腔内崩壊錠（ODT）賦形剤の産業チェーンを掲載しています。 ・第13、14、15章では、口腔内崩壊錠（ODT）賦形剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 口腔内崩壊錠（ODT）賦形剤の概要 - タイプ別分析（2017年vs2021年vs2028年）：結合剤、流動化剤、希釈剤、崩壊剤、甘味料、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：抗精神病薬、抗てんかん薬、その他 - 世界の口腔内崩壊錠（ODT）賦形剤市場規模・予測 - 世界の口腔内崩壊錠（ODT）賦形剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - BASF、JRS Pharma、Roquette、ABF Ingredients、DFE Pharma、Evonik、Merck KGaA、Ashland、Meggle Pharma、Shin-Etsu、Fuji Chemical Industries、McePharma (Vivesa holding)、Cargill Incorporated、Daicel Corporation、Anhui Sunhere Pharmaceutical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：結合剤、流動化剤、希釈剤、崩壊剤、甘味料、その他 ・アプリケーション別分析2017年-2028年：抗精神病薬、抗てんかん薬、その他 ・口腔内崩壊錠（ODT）賦形剤の北米市場分析 - 口腔内崩壊錠（ODT）賦形剤の北米市場：タイプ別市場規模2017年-2028年 - 口腔内崩壊錠（ODT）賦形剤の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・口腔内崩壊錠（ODT）賦形剤のヨーロッパ市場分析 - ：口腔内崩壊錠（ODT）賦形剤のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：口腔内崩壊錠（ODT）賦形剤のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・口腔内崩壊錠（ODT）賦形剤のアジア太平洋市場分析 - 口腔内崩壊錠（ODT）賦形剤のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 口腔内崩壊錠（ODT）賦形剤のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・口腔内崩壊錠（ODT）賦形剤の南米市場分析 - 口腔内崩壊錠（ODT）賦形剤の南米市場：タイプ別市場規模2017年-2028年 - 口腔内崩壊錠（ODT）賦形剤の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・口腔内崩壊錠（ODT）賦形剤の中東・アフリカ市場分析 - 口腔内崩壊錠（ODT）賦形剤の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 口腔内崩壊錠（ODT）賦形剤の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Orally Dissolving Tablets (ODT) Excipient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Orally Dissolving Tablets (ODT) Excipient market size is estimated to be worth US$ 17130 million in 2021 and is forecast to a readjusted size of USD 21480 million by 2028 with a CAGR of 3.3% during review period. Anti-Psychotics Drug accounting for % of the Orally Dissolving Tablets (ODT) Excipient global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Binders segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Orally Dissolving Tablets (ODT) Excipient include BASF, JRS Pharma, Roquette, ABF Ingredients, and DFE Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Orally Dissolving Tablets (ODT) Excipient market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Binders
Glidents
Diluents
Disintegrants
Sweeteners
Others
Market segment by Application can be divided into
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
The key market players for global Orally Dissolving Tablets (ODT) Excipient market are listed below:
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orally Dissolving Tablets (ODT) Excipient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orally Dissolving Tablets (ODT) Excipient, with price, sales, revenue and global market share of Orally Dissolving Tablets (ODT) Excipient from 2019 to 2022.
Chapter 3, the Orally Dissolving Tablets (ODT) Excipient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Dissolving Tablets (ODT) Excipient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Orally Dissolving Tablets (ODT) Excipient market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Orally Dissolving Tablets (ODT) Excipient.
Chapter 13, 14, and 15, to describe Orally Dissolving Tablets (ODT) Excipient sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Orally Dissolving Tablets (ODT) Excipient Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orally Dissolving Tablets (ODT) Excipient Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Sweeteners
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Orally Dissolving Tablets (ODT) Excipient Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Global Orally Dissolving Tablets (ODT) Excipient Market Size & Forecast
1.4.1 Global Orally Dissolving Tablets (ODT) Excipient Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Orally Dissolving Tablets (ODT) Excipient Sales in Volume (2017-2028)
1.4.3 Global Orally Dissolving Tablets (ODT) Excipient Price (2017-2028)
1.5 Global Orally Dissolving Tablets (ODT) Excipient Production Capacity Analysis
1.5.1 Global Orally Dissolving Tablets (ODT) Excipient Total Production Capacity (2017-2028)
1.5.2 Global Orally Dissolving Tablets (ODT) Excipient Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Orally Dissolving Tablets (ODT) Excipient Market Drivers
1.6.2 Orally Dissolving Tablets (ODT) Excipient Market Restraints
1.6.3 Orally Dissolving Tablets (ODT) Excipient Trends Analysis
2 Manufacturers Profiles
2.1 BASF
2.1.1 BASF Details
2.1.2 BASF Major Business
2.1.3 BASF Orally Dissolving Tablets (ODT) Excipient Product and Services
2.1.4 BASF Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 JRS Pharma
2.2.1 JRS Pharma Details
2.2.2 JRS Pharma Major Business
2.2.3 JRS Pharma Orally Dissolving Tablets (ODT) Excipient Product and Services
2.2.4 JRS Pharma Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roquette
2.3.1 Roquette Details
2.3.2 Roquette Major Business
2.3.3 Roquette Orally Dissolving Tablets (ODT) Excipient Product and Services
2.3.4 Roquette Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 ABF Ingredients
2.4.1 ABF Ingredients Details
2.4.2 ABF Ingredients Major Business
2.4.3 ABF Ingredients Orally Dissolving Tablets (ODT) Excipient Product and Services
2.4.4 ABF Ingredients Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 DFE Pharma
2.5.1 DFE Pharma Details
2.5.2 DFE Pharma Major Business
2.5.3 DFE Pharma Orally Dissolving Tablets (ODT) Excipient Product and Services
2.5.4 DFE Pharma Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Evonik
2.6.1 Evonik Details
2.6.2 Evonik Major Business
2.6.3 Evonik Orally Dissolving Tablets (ODT) Excipient Product and Services
2.6.4 Evonik Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck KGaA
2.7.1 Merck KGaA Details
2.7.2 Merck KGaA Major Business
2.7.3 Merck KGaA Orally Dissolving Tablets (ODT) Excipient Product and Services
2.7.4 Merck KGaA Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ashland
2.8.1 Ashland Details
2.8.2 Ashland Major Business
2.8.3 Ashland Orally Dissolving Tablets (ODT) Excipient Product and Services
2.8.4 Ashland Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Meggle Pharma
2.9.1 Meggle Pharma Details
2.9.2 Meggle Pharma Major Business
2.9.3 Meggle Pharma Orally Dissolving Tablets (ODT) Excipient Product and Services
2.9.4 Meggle Pharma Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Shin-Etsu
2.10.1 Shin-Etsu Details
2.10.2 Shin-Etsu Major Business
2.10.3 Shin-Etsu Orally Dissolving Tablets (ODT) Excipient Product and Services
2.10.4 Shin-Etsu Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Fuji Chemical Industries
2.11.1 Fuji Chemical Industries Details
2.11.2 Fuji Chemical Industries Major Business
2.11.3 Fuji Chemical Industries Orally Dissolving Tablets (ODT) Excipient Product and Services
2.11.4 Fuji Chemical Industries Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 McePharma (Vivesa holding)
2.12.1 McePharma (Vivesa holding) Details
2.12.2 McePharma (Vivesa holding) Major Business
2.12.3 McePharma (Vivesa holding) Orally Dissolving Tablets (ODT) Excipient Product and Services
2.12.4 McePharma (Vivesa holding) Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Cargill Incorporated
2.13.1 Cargill Incorporated Details
2.13.2 Cargill Incorporated Major Business
2.13.3 Cargill Incorporated Orally Dissolving Tablets (ODT) Excipient Product and Services
2.13.4 Cargill Incorporated Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Daicel Corporation
2.14.1 Daicel Corporation Details
2.14.2 Daicel Corporation Major Business
2.14.3 Daicel Corporation Orally Dissolving Tablets (ODT) Excipient Product and Services
2.14.4 Daicel Corporation Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Anhui Sunhere Pharmaceutical
2.15.1 Anhui Sunhere Pharmaceutical Details
2.15.2 Anhui Sunhere Pharmaceutical Major Business
2.15.3 Anhui Sunhere Pharmaceutical Orally Dissolving Tablets (ODT) Excipient Product and Services
2.15.4 Anhui Sunhere Pharmaceutical Orally Dissolving Tablets (ODT) Excipient Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Orally Dissolving Tablets (ODT) Excipient Breakdown Data by Manufacturer
3.1 Global Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Orally Dissolving Tablets (ODT) Excipient Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Orally Dissolving Tablets (ODT) Excipient
3.4 Market Concentration Rate
3.4.1 Top 3 Orally Dissolving Tablets (ODT) Excipient Manufacturer Market Share in 2021
3.4.2 Top 6 Orally Dissolving Tablets (ODT) Excipient Manufacturer Market Share in 2021
3.5 Global Orally Dissolving Tablets (ODT) Excipient Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Orally Dissolving Tablets (ODT) Excipient Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Orally Dissolving Tablets (ODT) Excipient Market Size by Region
4.1.1 Global Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Region (2017-2028)
4.1.2 Global Orally Dissolving Tablets (ODT) Excipient Revenue by Region (2017-2028)
4.2 North America Orally Dissolving Tablets (ODT) Excipient Revenue (2017-2028)
4.3 Europe Orally Dissolving Tablets (ODT) Excipient Revenue (2017-2028)
4.4 Asia-Pacific Orally Dissolving Tablets (ODT) Excipient Revenue (2017-2028)
4.5 South America Orally Dissolving Tablets (ODT) Excipient Revenue (2017-2028)
4.6 Middle East and Africa Orally Dissolving Tablets (ODT) Excipient Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Type (2017-2028)
5.2 Global Orally Dissolving Tablets (ODT) Excipient Revenue by Type (2017-2028)
5.3 Global Orally Dissolving Tablets (ODT) Excipient Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Application (2017-2028)
6.2 Global Orally Dissolving Tablets (ODT) Excipient Revenue by Application (2017-2028)
6.3 Global Orally Dissolving Tablets (ODT) Excipient Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Orally Dissolving Tablets (ODT) Excipient Sales by Type (2017-2028)
7.2 North America Orally Dissolving Tablets (ODT) Excipient Sales by Application (2017-2028)
7.3 North America Orally Dissolving Tablets (ODT) Excipient Market Size by Country
7.3.1 North America Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Country (2017-2028)
7.3.2 North America Orally Dissolving Tablets (ODT) Excipient Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Orally Dissolving Tablets (ODT) Excipient Sales by Type (2017-2028)
8.2 Europe Orally Dissolving Tablets (ODT) Excipient Sales by Application (2017-2028)
8.3 Europe Orally Dissolving Tablets (ODT) Excipient Market Size by Country
8.3.1 Europe Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Country (2017-2028)
8.3.2 Europe Orally Dissolving Tablets (ODT) Excipient Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Orally Dissolving Tablets (ODT) Excipient Sales by Type (2017-2028)
9.2 Asia-Pacific Orally Dissolving Tablets (ODT) Excipient Sales by Application (2017-2028)
9.3 Asia-Pacific Orally Dissolving Tablets (ODT) Excipient Market Size by Region
9.3.1 Asia-Pacific Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Orally Dissolving Tablets (ODT) Excipient Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Orally Dissolving Tablets (ODT) Excipient Sales by Type (2017-2028)
10.2 South America Orally Dissolving Tablets (ODT) Excipient Sales by Application (2017-2028)
10.3 South America Orally Dissolving Tablets (ODT) Excipient Market Size by Country
10.3.1 South America Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Country (2017-2028)
10.3.2 South America Orally Dissolving Tablets (ODT) Excipient Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Sales by Type (2017-2028)
11.2 Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Sales by Application (2017-2028)
11.3 Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Market Size by Country
11.3.1 Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Orally Dissolving Tablets (ODT) Excipient Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Orally Dissolving Tablets (ODT) Excipient and Key Manufacturers
12.2 Manufacturing Costs Percentage of Orally Dissolving Tablets (ODT) Excipient
12.3 Orally Dissolving Tablets (ODT) Excipient Production Process
12.4 Orally Dissolving Tablets (ODT) Excipient Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Orally Dissolving Tablets (ODT) Excipient Typical Distributors
13.3 Orally Dissolving Tablets (ODT) Excipient Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer